BusinessMomenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMay 8, 2018, 11:01 AM UTC
BusinessThe American College of Rheumatology Recommends Biosimilar Use in New White PaperBy Nasdaq OMXFeb 7, 2018, 8:57 PM UTC
BusinessRheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and CompetitionBy Nasdaq OMXJan 30, 2018, 7:13 PM UTC
Business109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug CostsBy Nasdaq OMXJan 18, 2018, 8:43 PM UTC
BusinessEPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 15, 2016, 10:00 AM UTC
BusinessEPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Provide Business UpdateBy Nasdaq OMXMar 1, 2016, 1:00 PM UTC
BusinessEPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for BOW015 (Infliximab Biosimilar)By Nasdaq OMXFeb 9, 2016, 12:00 PM UTC
BusinessEPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare Event on February 12By Nasdaq OMXFeb 5, 2016, 9:01 PM UTC
